Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Total Equity · Q4 FY2024 · quarter ended Mar 2025
Total equity turns positive
Q4 FY2024 total equity was $49.24K, compared with -$1.15M a year earlier.
Context
- Total equity amounted to 0.9% of total assets at the end of Q4 FY2024, down 22.6 pp from a year earlier.
- Total equity increased in 2 of the last 2 fiscal years.
- FY2024 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +104.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2024
- 49.24K USD
- Year-over-year change
- +104.3%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 49.24K | +104.3% |
| FY2023 | 2024-03-31 | (1.15M) | +9.7% |
| FY2022 | 2023-03-31 | (1.27M) | — |
Total Equity vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 total equity of $49.24K is the 9th highest of the 10 companies compared; the peer median is $204.53M.
- Its year-over-year change of +104.3% is the 2nd highest of 10, against a peer median of -16.1%.
- Total equity amounts to 0.9% of total assets for MCTA, versus a peer median of 77.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $367.07M | +23906.7% | +1005.1% | 59.1% | |
| Mar 2026 | $312.81M | -25.2% | -11.0% | 69.3% | |
| Mar 2026 | $267.3M | -4.3% | +45.3% | 87.9% | |
| Mar 2026 | $217.87M | +5.9% | +21.7% | 80.1% | |
| Mar 2026 | $204.53M | -16.1% | -2.9% | 77.8% | |
| Mar 2026 | $181.43M | -63.7% | -50.4% | 12.1% | |
| Feb 2026 | $133.77M | -29.4% | -11.2% | 91.3% | |
| Mar 2026 | $112.71M | +40.5% | — | 90.3% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $49.24K | +104.3% | — | 0.9% |
| Mar 2026 | -$16.29M | -421.3% | — | 9.7% | |
| Peer median (excluding MCTA) | $204.53M | -16.1% | -2.9% | 77.8% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.